West syndrome or West's Syndrome is an uncommon to rare epileptic disorder in infants. West syndrome was named after the English doctor and surgeon William James West (1793-1848), who lived in ...

The upcoming therapies, Epidiolex by GW Pharmaceuticals and JBPOS0101 by BioPharm Solutions, are anticipated to generate a decent West Syndrome market revenue in the forecast period of 2021-2030 ...

West syndrome, the most prevalent type of syndromic epileptic encephalopathy affecting infants, is a devastating and often fatal condition. It is characterized by a triad of symptoms -- seizures ...

There are approximately 5+ key companies developing the West Syndrome drugs. The companies with West Syndrome drug candidates in the most advanced stage are GW Pharmaceuticals and Bio-Pharm ...

West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births. To get ...

West syndrome is a severe form of epilepsy most common in infancy. It is characterized by infantile spasms, hypsarrhythmia and mental deficiency. With this said, diagnosis of West syndrome can ...

Citation: An animal model of West syndrome exhibits a progressive increase in epileptic spasms and learning and memory deficits (2022, November 3) retrieved 15 May 2025 from https://medicalxpress ...